Clinical Trials on Non-Alcoholic Steatohepatitis(NASH)
Total 1315 results
-
Altimmune, Inc.Completed
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.CompletedNonalcoholic Steatohepatitis (NASH)China
-
Navidea BiopharmaceuticalsCompletedNonalcoholic Steatohepatitis | NASH - Nonalcoholic SteatohepatitisUnited States
-
University of AarhusCompleted
-
Promethera TherapeuticsCompletedNASH - Nonalcoholic SteatohepatitisSpain, Belgium, Bulgaria, France
-
Novartis PharmaceuticalsCompletedObese Patients With Non-alcoholic Steatohepatitis (NASH)Netherlands, Taiwan, Thailand, United States, Israel, Argentina, Russian Federation, Canada
-
Tasly Pharmaceutical Group Co., LtdRecruiting
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Japan, Sweden
-
Alnylam PharmaceuticalsTerminatedNonalcoholic Steatohepatitis | NASHUnited States, Bulgaria, United Kingdom, Belgium, Turkey
-
HBI Solutions Inc.mProbe Inc.Not yet recruitingNAFLD | NASH - Nonalcoholic Steatohepatitis
-
Russian Academy of Medical SciencesFederal State Budgetary Scientific Institution "Federal Research Centre of...UnknownNAFLD | NASH - Nonalcoholic SteatohepatitisRussian Federation
-
Enyo PharmaCompletedHealthy | NASH - Nonalcoholic SteatohepatitisAustralia
-
HepQuant, LLCTerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
AstraZenecaRecruiting
-
89bio, Inc.RecruitingMetabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisUnited States
-
Harokopio UniversityUniversity of AthensCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Greece
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States
-
Erasme University HospitalEpidemiological and Clinical Research Information NetworkRecruitingNASH - Nonalcoholic SteatohepatitisBelgium
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
Jeffrey BrowningNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHealthy | NASH (Non-Alcoholic Steatohepatitis) | NAFLD (Non-Alcoholic Fatty Liver Disease)United States
-
Conatus Pharmaceuticals Inc.TerminatedLiver Diseases | Liver Cirrhosis | Liver Fibrosis | NASH Fibrosis | Decompensated Non-Alcoholic Steatohepatitis Cirrhosis | Orthotopic Liver TransplantationUnited States
-
Michael Ohliger, MD PhDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNAFLD | Non-Alcoholic Fatty Liver Disease | NASH | Non Alcoholic Fatty Liver | Non Alcoholic SteatohepatitisUnited States
-
Assiut UniversityNot yet recruiting
-
Viking Therapeutics, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
89bio, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Erasme University HospitalFractyl Laboratories, Inc.Completed
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Stefania BasiliUniversity of Roma La SapienzaRecruitingNAFLD | NASH - Nonalcoholic SteatohepatitisItaly
-
Gannex Pharma Co., Ltd.WithdrawnNonalcoholic Steatohepatitis (NASH)
-
Maastricht University Medical CenterNot yet recruitingPediatric Obesity | Childhood Obesity | NAFLD | NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | NASH | Childhood OverweightNetherlands
-
BASF ASUnknownNASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Fatty LiverUnited States
-
Blade TherapeuticsCompletedNASH - Nonalcoholic Steatohepatitis | Chronic Liver DiseaseAustralia
-
Cairo UniversityElsahel teaching hospitalCompletedNAFLD | NASH - Nonalcoholic SteatohepatitisEgypt
-
89bio, Inc.RecruitingMetabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With FibrosisUnited States
-
Duke UniversityCompletedLiver Diseases | Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
University Hospital, GrenobleInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement...RecruitingHBV | NASH - Nonalcoholic SteatohepatitisFrance
-
Medical College of WisconsinENDRA Life Sciences, Inc.RecruitingFatty Liver | NAFLD | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty Liver | NASH | Fatty Liver DiseaseUnited States
-
AstraZenecaTerminatedNonalcoholic SteatohapatitisUnited States
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsActive, not recruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverUnited Kingdom, Finland, Sweden, Spain, Greece, United States, Switzerland, Italy, France, Germany
-
Changi General HospitalUnknownWeight Loss | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Singapore
-
Instituto de Investigación Marqués de ValdecillaPuerta de Hierro University Hospital; Hospital Universitario La FeUnknownMain Hypothesis is That in the NASH Associated to IMIDs, to Different Phenotypes co ExistSpain
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...